Research and Markets (http://www.researchandmarkets.com/research/lm59ck/short_bowel) has announced the addition of the "Short Bowel Syndrome-Pipeline Insights, 2014" subscription to their offering.
This Short Bowel Syndrome-Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Short Bowel Syndrome.
This report provides information on the therapeutic development based on the Short Bowel Syndrome dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND Filed, Pre-Clinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule-type drug information.
The report also covers the companies' information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Key Topics Covered:
- Short Bowel Syndrome Overview
- Short Bowel Syndrome Pipeline Therapeutics
- Short Bowel Syndrome Therapeutics Under Development by Companies
- Short Bowel Syndrome Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Short Bowel Syndrome Mid-Clinical Stage Products (Phase II)
- Comparative Analysis
- Short Bowel Syndrome Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Short Bowel Syndrome Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Short Bowel Syndrome - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Short Bowel Syndrome - Discontinued Products
- Short Bowel Syndrome - Dormant Products
- Companies Involved in Therapeutics Development for Short Bowel Syndrome
- Appendix
For more information visit http://www.researchandmarkets.com/research/lm59ck/short_bowel.